.-The purpose of this study was to characterize vascular responses and to examine mechanisms of vascular dysfunction in TallyHo mice, a new polygenic model of Type II diabetes. Responses of cerebral arterioles and carotid arteries were examined in vivo by using a cranial window and in vitro by using tissue baths, respectively. Dilatation of cerebral arterioles (baseline diameter ϭ 33 Ϯ 1 m) in response to acetylcholine, but not to nitroprusside, was markedly reduced (P Ͻ 0.05) in TallyHo mice. Responses of cerebral arterioles to acetylcholine in TallyHo mice were restored to normal with polyethylene glycol-superoxide dismutase (100 U/ml; a superoxide scavenger). Responses to acetylcholine were also greatly impaired (P Ͻ 0.05) in the carotid arteries from TallyHo mice. Phenylephrine-and serotonin-, but not to KCl-or U46619-, induced contraction was increased two-to fourfold (P Ͻ 0.05) in carotid arteries of TallyHo mice. Responses to phenylephrine and serotonin were reduced to similar levels in the presence of Y-27632 (an inhibitor of Rho kinase; 3 mol/l). These findings provide the first evidence that vascular dysfunction is present in TallyHo mice and that oxidative stress and enhanced activity of Rho kinase may contribute to altered vascular function in this genetic model of Type II diabetes. carotid artery; cerebral circulation; endothelium; microcirculation EPIDEMIOLOGICAL STUDIES suggest that there is a marked increase in the number of vascular complications in patients with diabetes (21,22,51). For example, results from the Framingham study have found a two-to fourfold increased risk associated with diabetes and the development of other cardiovascular risk factors, including atherosclerosis, carotid artery disease, and stroke (21). Although Type II diabetes accounts for the majority (ϳ90%) of diabetes in humans (3), relatively little is known regarding vascular responses and mechanisms that produce vascular dysfunction in Type II diabetes compared with Type I diabetes.Whereas studies using ob/ob (leptin-deficient) and db/db (leptin receptor-deficient mice) have provided much insight into vascular alterations in the genetic models of Type II diabetes (8,19,25,42,(43)(44)(45)(46), such monogenic deficiencies in leptin and the leptin receptor are rare and are not always associated with the development of diabetes in humans (14). TallyHo mice represent a newly defined polygenetic model of Type II diabetes and are characterized by hyperglycemia, hyperinsulinemia, hyperlipidemia, and moderate obesity (23,